BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 22, 2017
View Archived Issues
PharmaMar starts phase I study of PM-14 in solid tumors
Read More
IPH-5401 development transitions from arthritis to immuno-oncology
Read More
Novel OTC gene mutation tied to intermittent hyperammonemia
Read More
FDA approves BioCryst's Rapivab in pediatric patients
Read More
Paratek's omadacycline awarded third FDA QIDP designation
Read More
Novel PI4KII-BETA inhibitors discovered at Stanford, UC Oakland
Read More
ATB-200/AT-2221 receives U.S. orphan drug status for Pompe disease
Read More
Bill & Melinda Gates Foundation, Anacor present boron-containing pleuromutilins
Read More
Bayer discovers new BUB1 inhibitors
Read More
Otsuka divulges novel compounds for brain cancer
Read More
MUT gene mutation linked to methylmalonic aciduria
Read More
Great apes adenovirus multiantigenic vaccine enhances anti-PD1 therapy in vivo
Read More
Disarm Therapeutics announces USD 30 million series A financing
Read More
Abivax receives French regulatory approval to begin phase IIa study of ABX-464 in ulcerative colitis
Read More
FDA grants rare pediatric disease designation to Altemia for SCD in children
Read More
DxTerity collaborates with City of Hope on blood test to predict response to radiation therapy
Read More
Phase III trial of somavaratan in pediatric growth hormone deficiency does not meet primary endpoint
Read More
Cellectar Biosciences, Onconova Therapeutics to jointly develop phospholipid drug conjugates
Read More
Phase IIb study of EMI-137 begins
Read More
Karyopharm reports first-in-human data for KPT-9274
Read More
Soligenix receives funding to support phase III study of SGX-972
Read More
Provention Bio in-licenses two clinical-stage assets from Janssen
Read More